Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion.

Galasso M, Feld JJ, Watanabe Y, Pipkin M, Summers C, Ali A, Qaqish R, Chen M, Ribeiro RVP, Ramadan K, Pires L, Bagnato VS, Kurachi C, Cherepanov V, Moonen G, Gazzalle A, Waddell TK, Liu M, Keshavjee S, Wilson BC, Humar A, Cypel M.

Nat Commun. 2019 Jan 29;10(1):481. doi: 10.1038/s41467-018-08261-z.

2.

Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neurons.

Niespodziany I, Rigo JM, Moonen G, Matagne A, Klitgaard H, Wolff C.

Epilepsia. 2017 Nov;58(11):e157-e161. doi: 10.1111/epi.13890. Epub 2017 Aug 29.

3.

Tetanus toxin production is triggered by the transition from amino acid consumption to peptides.

Licona-Cassani C, Steen JA, Zaragoza NE, Moonen G, Moutafis G, Hodson MP, Power J, Nielsen LK, Marcellin E.

Anaerobe. 2016 Oct;41:113-124. doi: 10.1016/j.anaerobe.2016.07.006. Epub 2016 Aug 1.

4.

[Loss of balance, gait disturbance and falls in an elderly woman].

Moonen G, Lievens I, Bianchi E.

Rev Med Liege. 2015 Oct;70(10):517-26. French.

5.

A New Acute Impact-Compression Lumbar Spinal Cord Injury Model in the Rodent.

Moonen G, Satkunendrarajah K, Wilcox JT, Badner A, Mothe A, Foltz W, Fehlings MG, Tator CH.

J Neurotrauma. 2016 Feb 1;33(3):278-89. doi: 10.1089/neu.2015.3937. Epub 2015 Dec 1.

6.

[Recurring vertigo].

Moonen V, Andris C, Moonen G.

Rev Med Liege. 2014 Oct;69(10):571-9. French.

7.

MicroRNA targeting of CoREST controls polarization of migrating cortical neurons.

Volvert ML, Prévot PP, Close P, Laguesse S, Pirotte S, Hemphill J, Rogister F, Kruzy N, Sacheli R, Moonen G, Deiters A, Merkenschlager M, Chariot A, Malgrange B, Godin JD, Nguyen L.

Cell Rep. 2014 May 22;7(4):1168-83. doi: 10.1016/j.celrep.2014.03.075. Epub 2014 May 1.

8.

A role for the canonical nuclear factor-κB pathway in coupling neurotrophin-induced differential survival of developing spiral ganglion neurons.

Vandenbosch R, Chocholova E, Robe PA, Wang Y, Lambert C, Moonen G, Lallemend F, Malgrange B, Hadjab S.

Front Cell Neurosci. 2013 Nov 28;7:242. doi: 10.3389/fncel.2013.00242. eCollection 2013.

9.

Expression of SV2 isoforms during rodent brain development.

Crèvecœur J, Foerch P, Doupagne M, Thielen C, Vandenplas C, Moonen G, Deprez M, Rogister B.

BMC Neurosci. 2013 Aug 9;14:87. doi: 10.1186/1471-2202-14-87.

10.

[Cerebrotendinous xanthomatosis, a rare, severe, but treatable metabolic disorder].

Delstanche S, Deflandre T, Otto B, Tshibanda L, Simoni P, Moonen G.

Rev Med Liege. 2013 Apr;68(4):171-6. French.

11.

Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis.

Crèvecoeur J, Kaminski RM, Rogister B, Foerch P, Vandenplas C, Neveux M, Mazzuferi M, Kroonen J, Poulet C, Martin D, Sadzot B, Rikir E, Klitgaard H, Moonen G, Deprez M.

Neuropathol Appl Neurobiol. 2014 Feb;40(2):191-204. doi: 10.1111/nan.12054.

PMID:
23617838
12.

Ephrin-A5/EphA4 signalling controls specific afferent targeting to cochlear hair cells.

Defourny J, Poirrier AL, Lallemend F, Mateo Sánchez S, Neef J, Vanderhaeghen P, Soriano E, Peuckert C, Kullander K, Fritzsch B, Nguyen L, Moonen G, Moser T, Malgrange B.

Nat Commun. 2013;4:1438. doi: 10.1038/ncomms2445.

PMID:
23385583
13.

[Academic neurology: between science and clinical research].

Moonen G.

Rev Med Liege. 2012 Dec;67(12):607-11. French. No abstract available.

14.

[Image of the month. Abnormal gluteal crease revealing Currarino syndrome].

Jedidi Z, Moonen G.

Rev Med Liege. 2012 Oct;67(10):499-500. French. No abstract available.

15.

Sleep in the unresponsive wakefulness syndrome and minimally conscious state.

Cologan V, Drouot X, Parapatics S, Delorme A, Gruber G, Moonen G, Laureys S.

J Neurotrauma. 2013 Mar 1;30(5):339-46. doi: 10.1089/neu.2012.2654. Epub 2013 Feb 20.

16.

p27(Kip1) is a microtubule-associated protein that promotes microtubule polymerization during neuron migration.

Godin JD, Thomas N, Laguesse S, Malinouskaya L, Close P, Malaise O, Purnelle A, Raineteau O, Campbell K, Fero M, Moonen G, Malgrange B, Chariot A, Metin C, Besson A, Nguyen L.

Dev Cell. 2012 Oct 16;23(4):729-44. doi: 10.1016/j.devcel.2012.08.006. Epub 2012 Sep 27.

17.

The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?

Phan-Ba R, Belachew S, Outteryck O, Moonen G, Sindic C, Vokaer M, Vermersch P.

Neurology. 2012 Sep 4;79(10):1067-9. doi: 10.1212/WNL.0b013e31826846b4. Epub 2012 Aug 22. No abstract available.

PMID:
22914844
18.

Sudden sensorineural hearing loss: when ophthalmology meets otolaryngology.

Karelle S, Demanez L, Zangerle PF, Blaise P, Moonen G, Poirrier AL.

B-ENT. 2012;8(2):135-9.

PMID:
22896934
19.

[Vitamin D tweets light to genes in multiple sclerosis].

Lommers E, Lecrompe L, Moonen G, Phan-Ba R, Belachew S.

Rev Med Liege. 2012 May-Jun;67(5-6):359-65. Review. French.

20.

MicroRNAs tune cerebral cortical neurogenesis.

Volvert ML, Rogister F, Moonen G, Malgrange B, Nguyen L.

Cell Death Differ. 2012 Oct;19(10):1573-81. doi: 10.1038/cdd.2012.96. Epub 2012 Aug 3. Review.

21.

A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.

Phan-Ba R, Calay P, Grodent P, Delrue G, Lommers E, Delvaux V, Moonen G, Nagels G, Belachew S.

NeuroRehabilitation. 2012;30(4):261-6. doi: 10.3233/NRE-2012-0754.

22.

[Clinical vignette for the medical school student: jugular foramen syndrome].

Moonen V, Ba RP, Tshibanda JF, Finck C, Moonen G.

Rev Med Liege. 2012 Apr;67(4):210-4. French.

23.

[Structured differential diagnosis of a transient impairment of consciousness].

Hansen I, Mélon P, Creemers E, Moonen G.

Rev Med Liege. 2012 Mar;67(3):157-62. French.

24.

Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis.

Phan-Ba R, Calay P, Grodent P, Delrue G, Lommers E, Delvaux V, Moonen G, Belachew S.

PLoS One. 2012;7(4):e34744. doi: 10.1371/journal.pone.0034744. Epub 2012 Apr 13.

25.

Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.

Garraux G, Caberg JH, Vanbellinghen JF, Jamar M, Bours V, Moonen G, Dive D.

Arch Neurol. 2012 Mar;69(3):398-400. doi: 10.1001/archneurol.2011.802.

PMID:
22410449
26.

Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

Phan-Ba R, Lommers E, Moonen G, Belachew S, Nath A.

Neurology. 2012 Jan 3;78(1):73; author response 73. doi: 10.1212/01.wnl.0000410335.08123.dc. No abstract available.

PMID:
22201114
27.

Functional neuroanatomy underlying the clinical subcategorization of minimally conscious state patients.

Bruno MA, Majerus S, Boly M, Vanhaudenhuyse A, Schnakers C, Gosseries O, Boveroux P, Kirsch M, Demertzi A, Bernard C, Hustinx R, Moonen G, Laureys S.

J Neurol. 2012 Jun;259(6):1087-98. doi: 10.1007/s00415-011-6303-7. Epub 2011 Nov 12.

28.

Cycling or not cycling: cell cycle regulatory molecules and adult neurogenesis.

Beukelaers P, Vandenbosch R, Caron N, Nguyen L, Moonen G, Malgrange B.

Cell Mol Life Sci. 2012 May;69(9):1493-503. doi: 10.1007/s00018-011-0880-6. Epub 2011 Nov 9. Review.

PMID:
22068613
29.

MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy.

Phan-Ba R, Lommers E, Tshibanda L, Calay P, Dubois B, Moonen G, Clifford D, Belachew S.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):224-6. doi: 10.1136/jnnp-2011-300511. Epub 2011 Oct 19.

31.

Automated EEG entropy measurements in coma, vegetative state/unresponsive wakefulness syndrome and minimally conscious state.

Gosseries O, Schnakers C, Ledoux D, Vanhaudenhuyse A, Bruno MA, Demertzi A, Noirhomme Q, Lehembre R, Damas P, Goldman S, Peeters E, Moonen G, Laureys S.

Funct Neurol. 2011 Jan-Mar;26(1):25-30.

32.

From unresponsive wakefulness to minimally conscious PLUS and functional locked-in syndromes: recent advances in our understanding of disorders of consciousness.

Bruno MA, Vanhaudenhuyse A, Thibaut A, Moonen G, Laureys S.

J Neurol. 2011 Jul;258(7):1373-84. doi: 10.1007/s00415-011-6114-x. Epub 2011 Jun 16. Review.

33.

Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosis.

Phan-Ba R, Lambinet N, Louis E, Delvenne P, Tshibanda L, Boverie J, Moonen G, Belachew S.

Inflamm Bowel Dis. 2011 Jun;17(6):E62-3. doi: 10.1002/ibd.21716. Epub 2011 Apr 6. No abstract available.

PMID:
21472830
34.

Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.

Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S.

Neurorehabil Neural Repair. 2011 Sep;25(7):672-9. doi: 10.1177/1545968310397204. Epub 2011 Mar 24.

PMID:
21436388
35.

Primary central nervous system lymphoma in a patient treated with natalizumab.

Phan-Ba R, Bisig B, Deprez M, De Prijck B, Delrue G, Herens C, Moonen G, Belachew S, de Leval L.

Ann Neurol. 2011 Jun;69(6):1060-1; author reply 1061-2. doi: 10.1002/ana.22296. Epub 2011 Feb 16. No abstract available.

PMID:
21328606
36.

Cdk6-dependent regulation of G(1) length controls adult neurogenesis.

Beukelaers P, Vandenbosch R, Caron N, Nguyen L, Belachew S, Moonen G, Kiyokawa H, Barbacid M, Santamaria D, Malgrange B.

Stem Cells. 2011 Apr;29(4):713-24. doi: 10.1002/stem.616.

37.

Primary diffuse leptomeningeal gliomatosis: an autopsy case and review of the literature.

Somja J, Boly M, Sadzot B, Moonen G, Deprez M.

Acta Neurol Belg. 2010 Dec;110(4):325-33. Review.

PMID:
21305863
38.

Attitudes towards end-of-life issues in disorders of consciousness: a European survey.

Demertzi A, Ledoux D, Bruno MA, Vanhaudenhuyse A, Gosseries O, Soddu A, Schnakers C, Moonen G, Laureys S.

J Neurol. 2011 Jun;258(6):1058-65. doi: 10.1007/s00415-010-5882-z. Epub 2011 Jan 8.

PMID:
21221625
39.

Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Malgrange B, Borgs L, Grobarczyk B, Purnelle A, Ernst P, Moonen G, Nguyen L.

Cell Mol Life Sci. 2011 Feb;68(4):635-49. doi: 10.1007/s00018-010-0557-6. Epub 2010 Oct 26. Review.

PMID:
20976521
40.

"Relevance vector machine" consciousness classifier applied to cerebral metabolism of vegetative and locked-in patients.

Phillips CL, Bruno MA, Maquet P, Boly M, Noirhomme Q, Schnakers C, Vanhaudenhuyse A, Bonjean M, Hustinx R, Moonen G, Luxen A, Laureys S.

Neuroimage. 2011 May 15;56(2):797-808. doi: 10.1016/j.neuroimage.2010.05.083. Epub 2010 Jun 4.

PMID:
20570741
41.

Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis.

Belachew S, Phan-Ba R, Bartholomé E, Delvaux V, Hansen I, Calay P, Hafsi KE, Moonen G, Tshibanda L, Vokaer M.

Eur J Neurol. 2011 Feb;18(2):240-5. doi: 10.1111/j.1468-1331.2010.03112.x.

42.

Two distinct neuronal networks mediate the awareness of environment and of self.

Vanhaudenhuyse A, Demertzi A, Schabus M, Noirhomme Q, Bredart S, Boly M, Phillips C, Soddu A, Luxen A, Moonen G, Laureys S.

J Cogn Neurosci. 2011 Mar;23(3):570-8. doi: 10.1162/jocn.2010.21488. Epub 2010 Jun 1.

PMID:
20515407
43.

Visual fixation in the vegetative state: an observational case series PET study.

Bruno MA, Vanhaudenhuyse A, Schnakers C, Boly M, Gosseries O, Demertzi A, Majerus S, Moonen G, Hustinx R, Laureys S.

BMC Neurol. 2010 May 26;10:35. doi: 10.1186/1471-2377-10-35.

44.

[Diagnostic exercise for the medical school student: how to analyze an abnormality of eye movements?].

Moonen V, Phan Ba R, Rikir E, Andris C, Moonen G.

Rev Med Liege. 2010 Jan;65(1):49-53. French.

45.

[Diagnostic exercise for the medical school student: teaching diagnostic reasoning].

Moonen G, Scheen AJ.

Rev Med Liege. 2010 Jan;65(1):46-8. French. No abstract available.

46.

Transcranial magnetic stimulation in disorders of consciousness.

Lapitska N, Gosseries O, Delvaux V, Overgaard M, Nielsen F, Maertens de Noordhout A, Moonen G, Laureys S.

Rev Neurosci. 2009;20(3-4):235-50. Review.

PMID:
20157993
47.

[MRI in coma survivors].

Tshibanda L, Vanhaudenhuyse A, Bruno MA, Boly M, Soddu A, Laureys S, Moonen G.

Rev Med Liege. 2009;64 Spec No:42-8. French.

48.

Default network connectivity reflects the level of consciousness in non-communicative brain-damaged patients.

Vanhaudenhuyse A, Noirhomme Q, Tshibanda LJ, Bruno MA, Boveroux P, Schnakers C, Soddu A, Perlbarg V, Ledoux D, Brichant JF, Moonen G, Maquet P, Greicius MD, Laureys S, Boly M.

Brain. 2010 Jan;133(Pt 1):161-71. doi: 10.1093/brain/awp313. Epub 2009 Dec 23.

49.

Severe liver dysfunction in a patient with multiple sclerosis: the guilty party is not always the disease-modifying therapy.

Hotermans C, Belachew S, Moonen G, Delwaide J.

Mult Scler. 2009 Nov;15(11):1378-9. doi: 10.1177/1352458509345910. No abstract available.

PMID:
19965562
50.

Neuroimaging after coma.

Tshibanda L, Vanhaudenhuyse A, Boly M, Soddu A, Bruno MA, Moonen G, Laureys S, Noirhomme Q.

Neuroradiology. 2010 Jan;52(1):15-24. doi: 10.1007/s00234-009-0614-8. Review.

Supplemental Content

Loading ...
Support Center